ecancermedicalscience

Research

Polymorphisms of uridine glucuronosyltransferase gene and irinotecan toxicity: low dose does not protect from toxicity

12 May 2014
Marianna Tziotou, Vassiliki Kalotychou, Anna Ntokou, Revekka Tzanetea, Iakovos Armenis, Marianna Varsou, Konstantinos Konstantopoulos, Nicolas Tsavaris, Yannis Rombos

Uridine glucuronosyltransferase (UGT) gene polymorphisms have been linked to irinotecan toxicity. Our purpose was to study the association between UGT1A1*28, UGT1A7*2, and UGT1A7*3 polymorphisms and irinotecan toxicity in Greek patients receiving low-dose weekly irinotecan. Blood samples were collected for 46 patients. DNA was extracted and UGT1A1 promoter and UGT1A7 exon 1 genotyping was carried out. Laboratory tests and physical examination were performed on regular basis for the assessment of toxicity. UGT1A1*28 was significantly correlated with both haematologic and non-haematologic toxicity. Moreover, patients carrying UGT1A7 polymorphisms had
significant incidence of toxicity. To conclude, UGT polymorphisms play a role in the toxicity of irinotecan, even if the drug is administered in low doses. The genotyping test may be a useful tool for the management of patients who are going to receive irinotecan.

Related Articles

Natalia Camejo, Camila Montenegro, Dahiana Amarillo, Cecilia Castillo, Gabriel Krygier
Asma’u Usman, Shamsu Sahalu Bello, Aisha Abdurrahman, Fatima Abubakar Rasheed, Shuaibu Adam, Abubakar Dahiru
Yosra Abdelmonem Zamzam, Yomna Zamzam, Ayman Elsaka, Lamiaa Al Fadaly, Tamer Haydara, Alaa Ibraheem Amer
Aditya Dhanawat, Mehak Trikha, Manan Vora, Himanshu Gujarathi, Vikas Ostwal, Prabhat Bhargava, Rajiv Kaushal, Anant Ramaswamy
Santiago Leandro Escobar-Dávila, Giovanna Patricia Rivas-Tafurt, Luis Álvaro Melo-Burbano, Luis Miguel Osorio-Toro, Edith Norela Benítez-Escobar, Duván Arley Galindes-Casanova, Jorge Hernán Izquierdo-Loaiza, Rodrigo Andrés Cárdenas-Perilla, Carlos Orozco-de la Hoz